Legend Biotech’s Post

#LegendNews: Today, we shared our third-quarter 2025 financial results. Our CEO, Ying Huang, reflects on our #CART #CellTherapies, key milestones & what’s ahead for $LEGN. Read the highlights: https://lnkd.in/e7Ugb7Am

  • No alternative text description for this image
Jeff Ashpitz

Managing Director, Strawn Arnold & Associates, Ltd.

1w

Congrats Ying on a great Q3.

Like
Reply
Joy-Ann Caesar

Clinical Laboratory Scientist at Sherman Abrams Labs

1w

That’s awesome

Like
Reply
See more comments

To view or add a comment, sign in

Explore content categories